Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00252057
Status:
COMPLETED
Last Update Posted:
2017-03-28
First Post:
2005-11-10
Brief Title:
Testing the Re-Engineered Hospital Discharge
Sponsor:
Boston University
Organization:
Boston University
Study Overview
Official Title:
Testing the Re-Engineered Hospital Discharge
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if the Re-Engineered Discharge will decrease rehospitalization rates and adverse events of patients leaving Boston Medical Center
Detailed Description:
This project responds to the problems of non-standardized care and discontinuity at hospital discharge Post-discharge adverse events are common and have been well documented However to date there are no studies demonstrating the effectiveness of any procedures or tools designed to reduce them This work builds on our Safe Practices Implementation Challenge Grant in which we developed the Reengineered Hospital Discharge tool a set of 10 discrete mutually reinforcing components Hypotheses The newly designed Re-engineered Hospital Discharge intervention will 1 reduce the percentage of patients experiencing a post-discharge adverse event and 2 reduce subsequent hospital utilization emergency department visits and rehospitalization within 30 days following hospital discharge Population Studied Patients from a network of Community Health Centers discharged from a general medical service at an urban hospital The subjects studied represent a low-income ethnically diverse urban population This study meets AHRQ guidelines for the inclusion of priority populations in research Methods 432 adult patients admitted to the general medical service of Boston Medical Center will be enrolled and randomized to 1 those receiving routine discharge as defined by our Process Map Control Group and 2 those receiving our Re-engineered Hospital Discharge intervention a set of 10 discrete mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist Intervention Group Outcome Measures The primary patient centered outcomes are the combined 30-day subsequent hospital utilization readmission and emergency department use and health status as measured by the SF-12 Process outcomes include the number and severity of the adverse events related to the discharge 30 days after discharge Although not a primary outcome an economic analysis will be completed Expected Results This project will provide valuable information about whether the Re-Engineered Discharge will reduce adverse events related to discharge and decrease subsequent hospital utilization DeliverablesDissemination An advisory committee of senior Boston Medical Center leaders will oversee the project and if proven effective will implement the intervention throughout our Academic Medical Center The Re-engineered Hospital Discharge tool will be widely generalizable and widely disseminated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None